High CXCL13 levels in the cerebrospinal fluid were demonstrated to correlate with increased B-cell recruitment in the CNS in a number of human disorders such as lymphoma, Lyme disease and multiple sclerosis (MS) [63,64,65]. This evidence concerns the gene CXCL13 and myeloid sarcoma.